FDA draft guidance on transdermal systems [BE/BA News]

posted by Ohlbe – France, 2023-04-13 10:37 (169 d 17:22 ago) – Posting: # 23523
Views: 652

Dear all,

If you're working on transdermal and topical delivery systems, you will be interested in two new FDA draft guidance documents:
- one on the assessment of irritation and sensitisation potential;
- one on the assessment of adhesion.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,763 posts in 4,775 threads, 1,627 registered users;
16 visitors (0 registered, 16 guests [including 10 identified bots]).
Forum time: 03:59 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5